 | bluebird bio, Inc. | |||
| NMS : BLUE || Location: United States | ||||
$0.91-0.01 (-0.82%) |
5.71 M | 0.88 - 0.93 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 29.747 M |
| March 15, 2024 | 34.041 M |
| Feb. 29, 2024 | 34.135 M |
| Feb. 15, 2024 | 28.588 M |
| Jan. 31, 2024 | 27.496 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.69 | -0.66 | 4.11% |
| 06/30/2023 | -0.73 | -0.67 | 8.21% |
| 03/31/2023 | -0.38 | 0.21 | 155.64% |
| 12/31/2022 | -0.44 | -0.81 | -82.15% |
| 09/30/2022 | -1.12 | -0.94 | 16.10% |
BLUE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 192.742M | Shares Float | 108.825M |
| Short Float | 29.747M | Market Cap | 177.32M |
| Institution ownership | 65.06% | Insider ownership | 0.378% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.63 | Forward EPS | -1.61 |